Novo Nordisk Aktie
50,28
EUR
+3,09
EUR
+6,55
%
51,70
EUR
+5,94
EUR
+12,97
%
Werbung
Novo Nordisk Aktie Analyse
18.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.09.19 | Novo Nordisk Neutral | Merrill Lynch & Co., Inc. | |
12.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.09.19 | Novo Nordisk Outperform | Bernstein Research | |
05.09.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.09.19 | Novo Nordisk buy | UBS AG | |
30.08.19 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
29.08.19 | Novo Nordisk Hold | Jefferies & Company Inc. | |
Werbung
|
|||
28.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
20.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
12.08.19 | Novo Nordisk Outperform | Credit Suisse Group | |
12.08.19 | Novo Nordisk Hold | Deutsche Bank AG | |
12.08.19 | Novo Nordisk Reduce | HSBC | |
09.08.19 | Novo Nordisk Equal weight | Barclays Capital | |
09.08.19 | Novo Nordisk buy | UBS AG | |
09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
02.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
31.07.19 | Novo Nordisk buy | UBS AG | |
08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
08.07.19 | Novo Nordisk Hold | Deutsche Bank AG | |
04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
18.06.19 | Novo Nordisk buy | UBS AG | |
17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
11.06.19 | Novo Nordisk buy | UBS AG | |
11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
28.05.19 | Novo Nordisk Reduce | HSBC | |
28.05.19 | Novo Nordisk Reduce | HSBC | |
17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
07.05.19 | Novo Nordisk buy | UBS AG | |
07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
07.05.19 | Novo Nordisk Reduce | HSBC | |
06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.05.19 | Novo Nordisk buy | UBS AG | |
29.04.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
29.04.19 | Novo Nordisk Outperform | Credit Suisse Group | |
12.04.19 | Novo Nordisk Outperform | Bernstein Research | |
11.04.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. |
Werbung
Werbung